In ApoE−/− mice, intraperitoneal α-MSH treatment significantly reduced the incidence and diameter of Ang II-induced AAA (Fig. 6B–D), which was accompanied with reduced expression of pro-inflammatory genes in the aorta (Fig. 6E). This evidence concerns the gene STAMBP and triple-A syndrome.